Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate
about
Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trialPrimaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmissionPrimaquine or other 8-aminoquinoline for reducing P. falciparum transmissionPrimaquine for reducing Plasmodium falciparum transmissionRationale for short course primaquine in Africa to interrupt malaria transmissionUsing genetic methods to define the targets of compounds with antimalarial activityThe activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasitesOptimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistanceQuality of antimalarial drugs and antibiotics in Papua New Guinea: a survey of the health facility supply chainHundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screenSingle dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: An open-label randomized trial.In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individualsComparison of four methods for extracting DNA from dried blood on filter paper for PCR targeting the mitochondrial Plasmodium genome.Malaria gametocytogenesis.Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs.Scalable preparation and differential pharmacologic and toxicologic profiles of primaquine enantiomers.Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screeningEffectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and eliminationAnti-malarial drugs and the prevention of malaria in the population of malaria endemic areas.The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South sumatra, Western indonesia: an open-label, randomized, controlled trial.Sub-microscopic gametocyte carriage in febrile children living in different areas of Gabon.Whole-cell in vitro screening for gametocytocidal compounds.Operational strategies to achieve and maintain malaria elimination.Comparison of detection methods to estimate asexual Plasmodium falciparum parasite prevalence and gametocyte carriage in a community survey in Tanzania.Human immune responses that reduce the transmission of Plasmodium falciparum in African populations.Epidemiology of Plasmodium infections in Flores Island, Indonesia using real-time PCR.Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations.Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malariaThe gametocytocidal efficacy of primaquine in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine in The Gambia (PRINOGAM): study protocol for a randomised controlled trialA cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania.Design and evaluation of primaquine-artemisinin hybrids as a multistage antimalarial strategy.The complexities of malaria disease manifestations with a focus on asymptomatic malariaIn Vitro Activities of Primaquine-Schizonticide Combinations on Asexual Blood Stages and Gametocytes of Plasmodium falciparumIvermectin inhibits the sporogony of Plasmodium falciparum in Anopheles gambiae.Routine delivery of artemisinin-based combination treatment at fixed health facilities reduces malaria prevalence in Tanzania: an observational study.Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common.Study protocol for a randomised controlled double-blinded trial of the dose-dependent efficacy and safety of primaquine for clearance of gametocytes in children with uncomplicated falciparum malaria in Uganda.Tools for mass screening of G6PD deficiency: validation of the WST8/1-methoxy-PMS enzymatic assay in Uganda.Nonrandomized controlled trial of artesunate plus sulfadoxine-pyrimethamine with or without primaquine for preventing posttreatment circulation of Plasmodium falciparum gametocytes.
P2860
Q21562479-3E17D5F1-F0C9-415B-8B8E-6324023FE34FQ24188070-402C2F37-F2A6-41C2-9592-1F0E2D87E37CQ24193716-7D2D2ED4-2EA1-4054-B688-FF0E90DABE7DQ24200471-D92B9189-1FF2-4F44-A059-F478B9C5014EQ27006552-6646A6A2-7EFF-43E8-BC4F-752DFB8D512AQ27014788-3DC49493-E85E-48E3-877C-FCD8488CB40DQ28480979-6880D40E-E57C-430A-9BFF-0447D15B02F3Q28483944-D805BFBA-3979-4938-9AB4-7EAF507C128BQ28538830-4AA26093-BFA4-40CB-8C27-9C777C9C73B4Q33720859-E99195A1-6B6D-4B52-B5B2-D561F11D40F4Q33772980-03205E3E-64EE-49B9-9CB7-A6B69EFCC9FCQ33826283-1D5E050B-A88A-4D02-A5D0-9CB190756AF6Q33893902-2F8BCD3C-4C78-4549-A91F-BAAC8224ABAAQ33894262-89CEA7AA-16D9-4D69-B095-3DE75977EDA2Q33898575-0F90F003-CD2C-4F8C-BFB5-6899F009D57EQ34058282-F957A7F0-006C-4961-88F0-BAD19A4DA0D5Q34099217-C8ED2C2C-411A-405D-87D9-D6A4E92C2C6EQ34164652-95219974-DA27-456A-BB87-4EBB4CB01B0AQ34177472-EC8FC4DF-AB02-49BF-BFBA-7102879178E0Q34407217-5C86AE81-B8E3-413D-9925-A5B34D506BD8Q34486508-5D1B89D0-087D-44F1-ABD2-3EA0D2E5FF5AQ34493765-9E7ED665-1ABE-4CCD-9A2E-11F4D4257A74Q34509609-1B1F6699-3D11-46F4-80DD-9E1E84DEBA2CQ34568019-3BF0C505-037C-46E1-BA78-F96DCB7943F2Q34582153-54FAAB44-5C3C-4319-9248-28CEF32CEE78Q34641186-E70224B1-E63A-4956-B3CF-FACF4DDA6BDCQ34739599-4FB62E8E-695F-4452-A80B-DFAA94665B49Q34922792-8915C2B8-A28B-410C-9CA5-62414D4C141DQ34968407-5A2E5CD5-38AB-492A-852A-837CBE35686CQ35147721-76997694-4E0D-4B3E-8CA7-C6DEFD0EA9B9Q35203887-253F3333-6E38-4C63-B72B-D1701C668046Q35270733-74CE332C-E920-4306-880C-990DFB7A057FQ35930447-AEA5BE49-737F-4894-A3DE-B89F0D365A8EQ36290632-18B9F532-CF45-4E78-A9D6-CDC64F6A691CQ36459407-3AA601E0-8980-4E61-A565-8E04C8BEE8C0Q36483241-31455B55-A3D2-455E-BC2B-A4BD280A2F79Q36538990-507F53F2-0BD1-4C8A-856C-74EDEA8C6126Q36730218-E7350CEA-7A79-4DCF-9F81-BCD1C804810BQ36952371-FB071ED0-0322-4F39-8EDD-53EE1FF7DC87Q36969682-F2121A43-F8EE-46BD-AF03-7EE70389FB48
P2860
Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Primaquine clears submicroscop ...... e-pyrimethamine and artesunate
@ast
Primaquine clears submicroscop ...... e-pyrimethamine and artesunate
@en
Primaquine clears submicroscop ...... e-pyrimethamine and artesunate
@nl
type
label
Primaquine clears submicroscop ...... e-pyrimethamine and artesunate
@ast
Primaquine clears submicroscop ...... e-pyrimethamine and artesunate
@en
Primaquine clears submicroscop ...... e-pyrimethamine and artesunate
@nl
prefLabel
Primaquine clears submicroscop ...... e-pyrimethamine and artesunate
@ast
Primaquine clears submicroscop ...... e-pyrimethamine and artesunate
@en
Primaquine clears submicroscop ...... e-pyrimethamine and artesunate
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
Primaquine clears submicroscop ...... e-pyrimethamine and artesunate
@en
P2093
Anders Enevold
Arnold Ndaro
Frank Mosha
Monique van Meegeren
Roly Gosling
Seif Shekalaghe
P2860
P3181
P356
10.1371/JOURNAL.PONE.0001023
P407
P577
2007-10-10T00:00:00Z